To investigate the neural substrates underlying EA's suppression of CRS‐induced hyperalgesia, we bilaterally delivered the excitatory chemogenetic vector AAV‐CaMKIIα‐hM3Dq‐mCherry into the VAL (Figure 4G,H). The gene discussed is CAMK2A; the disease is congenital rubella syndrome.